| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.2 | 0.3 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |